Cytotoxic Effects of Garcinia mangostana Pericarp Extract on Cancer Cell Lines.

Q3 Pharmacology, Toxicology and Pharmaceutics
Roghayeh Rashidi, Fatemeh Forouzanfar, Mohammad Soukhtanloo, Shirin Ghasemian, Seyed Hadi Mousavi
{"title":"Cytotoxic Effects of Garcinia mangostana Pericarp Extract on Cancer Cell Lines.","authors":"Roghayeh Rashidi,&nbsp;Fatemeh Forouzanfar,&nbsp;Mohammad Soukhtanloo,&nbsp;Shirin Ghasemian,&nbsp;Seyed Hadi Mousavi","doi":"10.2174/1570163819666220113100039","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Garcinia mangostana, commonly also called mangosteen, is an evergreen tropical tree, and its pericarps have been used in traditional herbal medicine for different diseases. The anticancer efficacy of the ethanolic extract from the pericarps of Garcinia mangostana was investigated in human prostate cancer cells (PC3), melanoma cells (B16F10), breast cancer cells (MCF7), and glioblastoma (U87) cell lines.</p><p><strong>Methods: </strong>3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay was used to measure cell viability. Propidium iodide (PI) staining and analysis on a flow cytometer were used to identify apoptosis. Action on cell migration was evaluated by scratch assay and gelatin zymography. Furthermore, the level of intracellular reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) activity was measured. Moreover, we investigated the synergistic efficacy with several combinations of Garcinia mangostana extract (GME) with doxorubicin.</p><p><strong>Results: </strong>GME reduced cell viability in malignant cell dose time-dependently. GME-induced sub- G1 peak in flow cytometry histogram of treated cells control representing apoptotic cell death is involved in GME toxicity. Furthermore, GME exhibited inhibitory effects on the migration ability of U87 cells, which was accompanied by inhibition in the activity and expression of MMP2 (matrix metalloproteinase-2). Besides, GSH level and SOD activity were significantly reduced while there was an increase in ROS and MDA concentration following 24 hr of GME treatment. Moreover, a combination of GME (1.5-25 μg/mL) with Dox (6 μg/mL) displayed synergistic efficacy and cell growth inhibition.</p><p><strong>Conclusion: </strong>In conclusion, GME could cause cell death in PC3, MCF7, U87, and B16F10 cell lines, in which apoptosis plays an imperative role. Plant extract decreased the migration ability of the cells by inhibiting the activity and expression of Matrix metalloproteinases (MMPs). G. mangostana could be a promising therapeutic strategy to treat cancer in the future.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e130122200196"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug discovery technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1570163819666220113100039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Garcinia mangostana, commonly also called mangosteen, is an evergreen tropical tree, and its pericarps have been used in traditional herbal medicine for different diseases. The anticancer efficacy of the ethanolic extract from the pericarps of Garcinia mangostana was investigated in human prostate cancer cells (PC3), melanoma cells (B16F10), breast cancer cells (MCF7), and glioblastoma (U87) cell lines.

Methods: 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay was used to measure cell viability. Propidium iodide (PI) staining and analysis on a flow cytometer were used to identify apoptosis. Action on cell migration was evaluated by scratch assay and gelatin zymography. Furthermore, the level of intracellular reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) activity was measured. Moreover, we investigated the synergistic efficacy with several combinations of Garcinia mangostana extract (GME) with doxorubicin.

Results: GME reduced cell viability in malignant cell dose time-dependently. GME-induced sub- G1 peak in flow cytometry histogram of treated cells control representing apoptotic cell death is involved in GME toxicity. Furthermore, GME exhibited inhibitory effects on the migration ability of U87 cells, which was accompanied by inhibition in the activity and expression of MMP2 (matrix metalloproteinase-2). Besides, GSH level and SOD activity were significantly reduced while there was an increase in ROS and MDA concentration following 24 hr of GME treatment. Moreover, a combination of GME (1.5-25 μg/mL) with Dox (6 μg/mL) displayed synergistic efficacy and cell growth inhibition.

Conclusion: In conclusion, GME could cause cell death in PC3, MCF7, U87, and B16F10 cell lines, in which apoptosis plays an imperative role. Plant extract decreased the migration ability of the cells by inhibiting the activity and expression of Matrix metalloproteinases (MMPs). G. mangostana could be a promising therapeutic strategy to treat cancer in the future.

山竹果皮提取物对癌细胞的细胞毒作用。
背景:山竹Garcinia mangostana,俗称山竹,是一种常绿的热带乔木,其果皮已被用于治疗不同疾病的传统草药。研究了山竹果皮乙醇提取物对人前列腺癌细胞(PC3)、黑色素瘤细胞(B16F10)、乳腺癌细胞(MCF7)和胶质母细胞瘤(U87)细胞系的抗癌作用。方法:采用3-[4,5-二甲基噻唑-2-基]-2,5二苯基溴化四唑(MTT)法测定细胞活力。用碘化丙啶(PI)染色和流式细胞仪分析细胞凋亡。用划痕法和明胶酶谱法评价其对细胞迁移的作用。测定细胞内活性氧(ROS)、丙二醛(MDA)、谷胱甘肽(GSH)水平和超氧化物歧化酶(SOD)活性。此外,我们还研究了山竹藤黄提取物(GME)与阿霉素的几种联合使用的增效效果。结果:GME降低恶性肿瘤细胞活力呈剂量时间依赖性。在流式细胞术中,GME诱导的亚G1峰表明GME毒性与细胞死亡有关。此外,GME对U87细胞的迁移能力有抑制作用,同时抑制基质金属蛋白酶2 (MMP2)的活性和表达。GME处理24小时后,GSH水平和SOD活性显著降低,ROS和MDA浓度升高。此外,GME (1.5 ~ 25 μg/mL)与Dox (6 μg/mL)联合使用具有协同作用和细胞生长抑制作用。结论:GME可引起PC3、MCF7、U87和B16F10细胞系细胞死亡,其中凋亡起重要作用。植物提取物通过抑制基质金属蛋白酶(MMPs)的活性和表达来降低细胞的迁移能力。山竹果可能是未来治疗癌症的一种很有前途的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug discovery technologies
Current drug discovery technologies Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
3.70
自引率
0.00%
发文量
48
期刊介绍: Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信